CartiHeal Ltd.

CartiHeal Ltd.

CartiHeal Ltd.

Date Founded



Atir Yeda 17,4th Floor,Kfar Saba, HaMerkaz 4464313

Type of Company


Employees (Worldwide)

501 - 1,000


Medical Products & Equipment
Industrial Machinery & Manufacturing
Hospitals & Patient Services
Holding Companies

Company Description

CartiHeal Ltd. operates as a medical device company which develops implants for the regeneration of cartilage and bone disorders. Its product includes Agili-C implant which promote regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous agents. The company was founded by Nir Altschuler in 2009 and is headquartered in Kfar Saba, Israel.

Executives & Employees


Medical Director

General Partner

Board of Directors

General Partner at CartiHeal Ltd.

Head of Healthcare at Elron Electronic Industries Ltd.

Founder & Managing Partner at A.M. Accelmed Management (2009) Ltd.

Founder at CartiHeal Ltd.

Chief Executive Officer at Elron Electronic Industries Ltd.

Paths to CartiHeal Ltd.
Potential Connections via
Relationship Science
CartiHeal Ltd.
Details Hidden

Bioventus LLC is a holding company, which manufactures medical equipment. It develops bone healing devices and distributes osteoarthritis injection therapies. Its products include ultrasound bone healing device, joint therapies, and osteoarthritis injection therapies. The company was founded in 2012 and is headquartered in Durham, NC.

Details Hidden

Access Medical Ventures focuses specifically on investing in interventional and therapeutic medical device start-up companies. The firm looks for companies with motivated management teams. Companies should also have proprietary technologies that address clear clinical needs, along with large market potential and validated business models. Access Medical Ventures also seeks to invest in opportunities in which there are capital efficient routes for obtaining regulatory approval and reimbursement.

Details Hidden

AccelMed is an active manager which aims to build state-of-the art medical device companies and lead them to success by investing in innovative late-stage medical device companies. Their geographic focus is on Israel.The firm typically seeks to invest USD 2-4 million as an initial allocation in companies with proven clinical data, a core team capable of taking the technology to the sales stage, technology that addresses a clear clinical need and has the potential to deliver better health outcomes than current technologies, strong intellectual property, a sustainable business model providing a clear and definable competitive advantage, proven market potential (at least USD 100 million in annual revenues), a clear regulatory pathway with preference to 510(k) regulatory path and an exit model.AccelMed takes significant stakes (usually above 33%) in their investee companies, partnering with management to assist in their strategic development. They seek board representation and continue to support the company with managerial assistance, direction and advice across all levels of the business, as needed.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CartiHeal Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CartiHeal Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and CartiHeal Ltd..